Procept (PRCT): 50% rise on high volume. Why? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Procept (PRCT): 50% rise on high volume. Why?

PRCT 29.67

-2.5%

Nov 14 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John B. Anderson who wrote (18)	8/23/1996 3:35:00 PM
From: John Crovelli	of 455

Let us all know Mary Ann's response regardless! ADVR is working with a drug called reticulose. It supposedly is effective against a broad range of viral infections, with potential indications for HIV and HPV among others. It has been around a long time. New research being done by respected Dr. at Mt. Sinai Med. Center in NYC. Also by credentialed Dr. in Argentina. Anyway, several reports are due out and the company has seemingly answered in recent S1 filing all the bad questions posed in a Barrons article several months ago. Its speculative for sure but seems interesting. 40% increase in stock price the last 2 weeks. SGA says 1.50 to 2.00 in next several months. Lots of good posts on the thread. Research paper due for publication 8/27 in JIM. Anyway, I got in fairly early and made a few $$ for a change. Still in PRCT very very long. Thanks again.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next